循环微小RNA与儿童哮喘治疗反应
该研究基于儿童哮喘管理计划(CAMP)中462例受试者的基线血清样本,经小RNA测序分析循环miRNA与4年ICS治疗期间FEV1%变化的关系。共发现7个miRNA与FEV1%变化显著相关、15个miRNA与ICS和安慰剂间存在显著交互作用;其中hsa-miR-155-5p与hsa-miR-532-5p联合预测ICS反应的ROC曲线下面积为0.86。
要点
- 基线循环miRNA可预测儿童哮喘对ICS的长期反应。
- hsa-miR-155-5p和hsa-miR-532-5p联合预测ICS反应AUC为0.86。
- 15个miRNA与ICS和安慰剂间存在显著交互作用(P≤0.05)。
核心结论
- 鉴定出两个功能性循环miRNA可预测儿童哮喘ICS治疗反应。
研究设计与样本
- 选取CAMP中随后随机分配至布地奈德ICS组或安慰剂组的462例受试者基线血清样本进行小RNA测序。
主要发现
- 7个miRNA与4年治疗期间FEV1%变化显著相关(P≤0.05)。
- 15个miRNA与ICS和安慰剂治疗间存在显著交互作用(P≤0.05)。
- hsa-miR-155-5p和hsa-miR-532-5p与地塞米松诱导的NF-κB反式抑制变化显著相关。
- 两miRNA联合预测ICS反应的ROC曲线下面积为0.86。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Inhaled corticosteroids (ICS) are key treatments for controlling asthma and preventing asthma attacks. However, the responsiveness to ICS varies among individuals. MicroRNAs (miRNAs) have been lauded for their prognostic utility.Objectives: We hypothesized that circulating miRNAs obtained at baseline/prerandomization in the Childhood Asthma Management Program (CAMP) could serve as biomarkers and biologic mediators of ICS clinical response over the 4-year clinical trial period.Methods: We selected baseline serum samples from 462 CAMP subjects subsequently randomized to either ICS (budesonide) or placebo. Samples underwent small RNA sequencing, and read counts were normalized and filtered by depth and coverage. Linear regression was used to associate miRNAs with change in FEV1% (prebronchodilator FEV1 as a percent predicted) over the 4-year treatment period in both main effects and interaction models. We validated the function of the top associated miRNAs by luciferase reporter assays of glucocorticoid-mediated transrepression and predicted response to ICS through logistic regression models.Measurements and Main Results: We identified 7 miRNAs significantly associated with FEV1% change (P ≤ 0.05) and 15 miRNAs with significant interaction (P ≤ 0.05) to ICS versus placebo treatments. We selected three miRNAs for functional validation, of which hsa-miR-155-5p and hsa-miR-532-5p were significantly associated with changes in dexamethasone-induced transrepression of NF-κB. Combined, these two miRNAs were predictive of ICS response over the course of the clinical trial, with an area under the receiver operating characteristic curve of 0.86.Conclusions: We identified two functional circulating miRNAs predictive of asthma ICS treatment response over time.
引用
- Li J, Panganiban R, Kho AT, et al. Circulating MicroRNAs and Treatment Response in Childhood Asthma. Am J Respir Crit Care Med. 2020. PMID: 32272022. doi:10.1164/rccm.201907-1454OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。